JG
AMAG

Joel Greenblatt’s AMAG Pharmaceuticals AMAG Stock Holding History

Joel Greenblatt’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-73,141
Closed -$969K – 1120
2017
Q4 		$969K Sell
73,141
-358,270
-83% -$5.4M 0.01% 594
2017
Q3 		$7.96M Sell
431,411
-368,644
-46% -$6.87M 0.12% 274
2017
Q2 		$14.7M Buy
800,055
+121,137
+18% +$2.4M 0.21% 156
2017
Q1 		$15.3M Buy
678,918
+78,334
+13% +$1.88M 0.19% 179
2016
Q4 		$20.9M Buy
600,584
+92,775
+18% +$2.77M 0.27% 124
2016
Q3 		$12.4M Buy
507,809
+95,897
+23% +$2.4M 0.16% 196
2016
Q2 		$9.85M Buy
411,912
+207,728
+102% +$4.76M 0.12% 279
2016
Q1 		$4.78M Sell
204,184
-12,272
-6% -$291K 0.05% 442
2015
Q4 		$6.54M Sell
216,456
-780,089
-78% -$25.2M 0.07% 368
2015
Q3 		$39.6M Buy
996,545
+485,948
+95% +$30.2M 0.39% 69
2015
Q2 		$35.3M Buy
+510,597
New +$32.1M 0.29% 116

Other funds holding AMAG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Joel Greenblatt's AMAG Position: Q1 2018 in Review

Joel Greenblatt sold out of AMAG Pharmaceuticals (AMAG) in Q1 2018, closing a stake of 73,141 shares — an estimated $969K sold.

Joel Greenblatt first reported a position in AMAG in Q2 2015 and held it in 11 quarters. The position peaked at $39.6M in Q3 2015. 170 funds tracked by Wall St. Rank hold AMAG as of Q1 2018.

  • Joel Greenblatt reported no remaining AMAG Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Joel Greenblatt sold 73,141 AMAG Pharmaceuticals shares in Q1 2018, an estimated $969K.
  • Joel Greenblatt first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 11 quarters.
  • Joel Greenblatt's AMAG Pharmaceuticals position peaked at $39.6M in Q3 2015.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2018.

Based on Gotham Asset Management's 13F filing for Q1 2018, filed 15 May 2018.